Results
Zydus Lifesciences FY26 Reports 17% Revenue Growth, Major Acquisitions
Zydus Lifesciences reported 17% revenue growth to ₹271.5 billion with 31.2% EBITDA margin and 11.4% PAT growth to ₹35.6 billion in FY26.
The company announced ₹1,100 crore share buyback at ₹1,260 per
